Literature DB >> 30734930

Micro-CT analysis of chronic apical periodontitis induced by several specific pathogens.

S Chen1,2, H Lei1,3, Y Luo1,3, S Jiang1,2, M Zhang1, H Lv1,3, Z Cai4, X Huang1,2.   

Abstract

AIM: To conduct three-dimensional micro-CT analysis of bone destruction, periapical sclerotic changes and inflammatory root resorption (IRR) to compare the differences between Enterococcus faecalis (Ef)- and Porphyromonas gingivalis (Pg)-induced chronic apical periodontitis (CAP).
METHODOLOGY: Mono-species bacteria-induced CAP was established in the first and second molars of the right maxilla and mandible of male Sprague-Dawley rats. Fifteen animals were divided into three groups with five rats in each group: control group, Ef-CAP group and Pg-CAP group. The maxilla and mandible were harvested and then scanned by micro-CT. Alveolar bone destruction was evaluated by measuring the volume of alveolar bone resorption, bone volume fraction (BV/TV), trabecular thickness (Tb. Th), trabecular number (Tb. N) and trabecular spacing (Tb. Sp). The results were analysed using one-way analysis of variance and Fisher's least significant difference methods (LSD). The sclerotic changes in the periapical bone were graded and the IRR indexes were scored. The data were analysed using the chi-square test.
RESULTS: The alveolar bone resorption volume of the Pg-CAP group was significantly larger than that of the Ef-CAP group (P < 0.01). In the maxilla, both Pg-CAP and Ef-CAP groups had a significant decrease in BV/TV and increase in Tb. Sp (P < 0.01) with the more significant changes of trabecular bone in the Pg-CAP group. A significant reduction of Tb. N was only found in the Pg-CAP group (P < 0.05). There was no significant change in Tb. Th in either group (P > 0.05). In the mandible, except for an increase in Tb. Sp in the Pg-CAP group (P < 0.05), there was no significant change in BV/TV, Tb. Th or Tb. N (P > 0.05). No obvious sclerotic change was observed. IRR was detected in significantly more root surfaces in the Pg-CAP group (240 surfaces, 60%) than those in the Ef-CAP group (178 surfaces, 44.5%) (P < 0.001). The IRR extension was also significantly more advanced in the Pg-CAP group (P < 0.05).
CONCLUSIONS: Pg-CAP caused more substantial alveolar bone destruction and IRR than Ef-CAP. The maxilla was more susceptible to CAP in terms of microstructural changes of trabecular bone than the mandible. Tb. Sp was the most sensitive index for evaluating the residual alveolar bone of CAP.
© 2019 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Enterococcus faecaliszzm321990; zzm321990Porphyromonas gingivaliszzm321990; alveolar bone destruction; chronic apical periodontitis; micro-CT

Mesh:

Year:  2019        PMID: 30734930     DOI: 10.1111/iej.13095

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  4 in total

1.  Computed Tomography Three-Dimensional Reconstruction Algorithm in the Diagnosis of Periodontitis and Its Correlation with Hypertension.

Authors:  Lingling Xu; Jiaxin Pan; Jue Liu; Zhong Guan; Lu Zhao
Journal:  Comput Math Methods Med       Date:  2022-07-01       Impact factor: 2.809

2.  Chronic apical periodontitis exacerbates atherosclerosis in apolipoprotein E-deficient mice and leads to changes in the diversity of gut microbiota.

Authors:  Guowu Gan; Beibei Lu; Ren Zhang; Yufang Luo; Shuai Chen; Huaxiang Lei; Yijun Li; Zhiyu Cai; Xiaojing Huang
Journal:  Int Endod J       Date:  2021-11-16       Impact factor: 5.165

Review 3.  Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis.

Authors:  Xutao Luo; Qianxue Wan; Lei Cheng; Ruoshi Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

4.  Enterococcus faecalis-Induced Macrophage Necroptosis Promotes Refractory Apical Periodontitis.

Authors:  Xingzhu Dai; Rongyang Ma; Weiyi Jiang; Zilong Deng; Lijuan Chen; Yuee Liang; Longquan Shao; Wanghong Zhao
Journal:  Microbiol Spectr       Date:  2022-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.